Emily Stone, MBBS, PhD, of St Vincent’s Hospital, Sydney, Australia, has been named Editor-in-Chief of JTO Clinical and Research Reports (JTO CRR), the official open-access journal of the International Association for the Study of Lung Cancer (IASLC).
Under the leadership of Alex A. Adjei, MD, PhD, FACP, editor-in-chief of the Journal of Thoracic Oncology (JTO), JTO CRR was launched in early 2020 as an open-access companion for IASLC’s flagship journal to provide more opportunity for publishing manuscripts at a time when thoracic oncology research is expanding at a rapid pace.
“The IASLC and JTO have grown and matured during a rich and rewarding time for scientists and clinicians working to eradicate lung cancer,” Dr. Stone wrote in a recent JTO editorial. “Major developments in prevention, screening, early diagnosis, and management of thoracic malignancies have already improved outcomes. The addition of JTO CRR adds breadth to the scholarship supported by IASLC and opens new directions for our scientific community. The JTO CRR has had a sure start with its founding editor Prof. Adjei. I am privileged to take the baton for the next leg of the journey.”
Dr. Stone is a consultant respiratory physician and head of thoracic medicine within the Department of Thoracic Medicine and Lung Transplantation at St Vincent’s Hospital, where she established a clinic to treat lung cancer. She is also the founding and immediate past chair of the St. Vincent’s Hospital Lung Cancer Multidisciplinary Team.
Dr. Stone is the NSW Principal Investigator for the International Lung Screening Trial investigating optimal strategies in low-dose CT screening for lung cancer and works on the NHMRC-funded Care to Quit trial investigating smoking cessation in cancer clinics. She serves as the deputy board chair of the Thoracic Oncology Group of Australasia.
She also has extensive journal editing experience, which includes past roles as associate editor of JTO, associate editor of JTO CRR, and deputy editor of Respirology.
Dr. Stone earned her PhD from the University of Sydney in Clinical Data Science in Lung Cancer Multidisciplinary Care, following a 2021 Master of Medicine from the University of Sydney in Pulmonary Fibrosis, Bleomycin and Growth Factors. She served as a Fellow in the Royal Australasian College of Physicians and earned her MBBS from the University of Sydney in 1993.
JTO CRR aims to complement JTO by offering authors an open access option for publishing the following types of articles:
- Phase I trials
- Well-performed, single-arm phase II trials
- Subset analyses of published trials
- Impactful retrospective studies
- Database analysis
- Large institutional series
- High-quality case reports
- Region-specific clinical trials
- Subspecialty thoracic oncology studies
- Selected high-quality meeting reports
